|
⚲
|
| Keyboard |
| Doyle Anthony
✚
|
|
|---|---|
| CIK # | 0001808688 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001808688] | |
| 4 | [0001808688] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Doyle Anthony | |
| Biocryst Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2024-12-19 | Grant | 120,700 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2024-12-19 | Grant | 250,100 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2024-12-19 | Tax withheld | 2,461 | $7.39 | 18,187 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2024-12-14 | Tax withheld | 7,890 | $7.53 | 59,412 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2024-05-14 | Buy | 36,300 | $5.57 | 202,191 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2023-12-19 | Tax withheld | 2,482 | $6.05 | 15,016 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2023-12-14 | Grant | 34,000 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2023-12-14 | Tax withheld | 5,475 | $6.43 | 35,204 |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2023-12-14 | Grant | 158,500 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2022-12-19 | Grant | 34,000 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2022-12-19 | Grant | 158,500 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2022-12-15 | Sell | 5,700 | $10.90 | 62,130 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2021-12-14 | Grant | 115,000 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2021-12-14 | Grant | 164,000 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2021-11-23 | Buy | 35,258 | $12.48 | 440,020 |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2020-12-15 | Grant | 332,500 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2020-08-11 | Buy | 54,000 | $4.08 | 220,320 |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2020-04-30 | Grant | 600,000 | $0.00 |